“…In particular, nine of them harvested a sub‐epithelial CTG (Anderson et al., 2014; Bianchi & Sanfilippo, 2004; De Bruyckere et al., 2020; Huber et al., 2018; Hutton et al., 2018; Lorenzo et al., 2012; Thoma et al., 2016, 2020; Wiesner et al., 2010), two articles reported the outcomes (on the same cohort of patients) of CTG obtained from the de‐epithelialization of a free gingival graft (FGGs) (Zucchelli et al., 2013, 2018), one study utilized a CTG obtained from the de‐epithelialization of a gingival graft from the maxillary tuberosity (Roccuzzo et al., 2019), one trial utilized either sub‐epithelial CTG or a CTG obtained from the de‐epithelialization of a FGG (Cairo et al., 2017) and two studies did not specify the harvesting technique (Baldi et al., 2020; Fenner et al., 2016). PROMs of FGG were evaluated in two studies (Roccuzzo et al., 2016; Vellis et al., 2019), while three trials reported on acellular dermal matrix (ADM) (Anderson et al., 2014; Baldi et al., 2020; Hutton et al., 2018) and eight studies assessed the PROMs of xenogeneic collagen matrix (XCM) (Cairo et al., 2017; Froum et al., 2015; Huber et al., 2018; Lorenzo et al., 2012; Schallhorn et al., 2015; Thoma et al., 2016, 2020; Vellis et al., 2019). Five studies compared PROMs of grated vs. non‐grafted sites (Baldi et al., 2020; Bianchi & Sanfilippo, 2004; Froum et al., 2015; Roccuzzo et al., 2016; Wiesner et al., 2010).…”